Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-21-029958
Filing Date
2021-05-28
Accepted
2021-05-28 16:33:00
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ea141829-defa14a_citius.htm DEFA14A 22742
2 GRAPHIC image_001.jpg GRAPHIC 4912
  Complete submission text file 0001213900-21-029958.txt   30822
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-38174 | Film No.: 21980848
SIC: 2834 Pharmaceutical Preparations